Alex Pharma posts 4.1% YoY increase in 3 months
Updated 11/7/2022 3:25:07 PM
Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) posted a 4.07% year-on-year (YoY) increase in net profit after tax for the first quarter (Q1) of fiscal year (FY) 2022/2023, according to the unaudited financial income statement filed to the Egyptian Exchange (EGX) on November 7th.
Net profit after tax amounted to EGP 34.587 million in the three-month period ended September 30th, compared to EGP 33.234 million in Q1 FY 2021/2022.
The company’s revenue rose to EGP 342.956 million in Q1 FY 2022/2023 from EGP 307.619 million the same period a FY earlier.
Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.
